Jean F. Holloway - Nov 14, 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Signature
/s/ Jean F Holloway
Stock symbol
AORT
Transactions as of
Nov 14, 2025
Transactions value $
-$197,751
Form type
4
Date filed
11/18/2025, 01:11 PM
Previous filing
Nov 14, 2025
Next filing
Dec 4, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Holloway Jean F SVP, General Counsel 1655 ROBERTS BLVD., NW, KENNESAW /s/ Jean F Holloway 2025-11-18 0001540065

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $189K +6.39K +3.91% $29.62 170K Nov 14, 2025 Direct F1
transaction AORT Common Stock Sale -$288K -6.39K -3.76% $45.00 163K Nov 14, 2025 Direct F1
transaction AORT Common Stock Options Exercise $189K +6.39K +3.91% $29.62 170K Nov 17, 2025 Direct F1
transaction AORT Common Stock Sale -$289K -6.39K -3.77% $45.17 163K Nov 17, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Options (Right to buy) Options Exercise $0 -6.39K -100% $0.00 0 Nov 14, 2025 Common Stock 6.39K $29.62 Direct F1, F2
transaction AORT Stock Options (Right to buy) Options Exercise $0 -6.39K -100% $0.00 0 Nov 17, 2025 Common Stock 6.39K $29.62 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025.
F2 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.